SEC Form 4 · accession 0001209191-15-054770
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
GALEN PARTNERS III L P
10% Owner
GALEN PARTNERS INTERNATIONAL III L P
10% Owner
GALEN EMPLOYEE FUND III LP
10% Owner
CLAUDIUS LLC
10% Owner
Galen Management, LLC
10% Owner
Period of report
Jun 16, 2015
Accepted (ET)
Jun 18, 2015 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 16, 2015 | S | 100,923 | $1.0844 | D | 10,982,574 | I | See FN |
| Common StockF4,F5 | Jun 17, 2015 | S | 3,900 | $1.05 | D | 10,978,674 | I | See FN |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold as follows: 92,199 by Galen Partners III, L.P. ("Galen III"), 8,345 by Galen Partners International III, L.P. ("Galen International") and 379 by Galen Employee Fund III, L.P. ("Employee Fund").
- F2The shares were sold at prices between $1.05 and $1.14. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares are held as follows: 10,036,254 by Galen III, 904,976 by Galen International and 41,344 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
- F4The shares were sold as follows: 3,563 by Galen III, 322 by Galen International and 15 by Employee Fund.
- F5The shares are held as follows: 10,032,691 by Galen III, 904,654 by Galen International and 41,329 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.